These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20229012)

  • 1. Multiple mechanisms of hERG liability: K+ current inhibition, disruption of protein trafficking, and apoptosis induced by amoxapine.
    Obers S; Staudacher I; Ficker E; Dennis A; Koschny R; Erdal H; Bloehs R; Kisselbach J; Karle CA; Schweizer PA; Katus HA; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2010 May; 381(5):385-400. PubMed ID: 20229012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.
    Jehle J; Ficker E; Wan X; Deschenes I; Kisselbach J; Wiedmann F; Staudacher I; Schmidt C; Schweizer PA; Becker R; Katus HA; Thomas D
    Br J Pharmacol; 2013 Mar; 168(5):1215-29. PubMed ID: 23061993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.
    Staudacher I; Wang L; Wan X; Obers S; Wenzel W; Tristram F; Koschny R; Staudacher K; Kisselbach J; Koelsch P; Schweizer PA; Katus HA; Ficker E; Thomas D
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):119-39. PubMed ID: 21120454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.
    Kiesecker C; Alter M; Kathöfer S; Zitron E; Scholz EP; Thomas D; Kreuzer J; Katus HA; Bauer A; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):212-20. PubMed ID: 16736158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.
    Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.
    Scherer D; von Löwenstern K; Zitron E; Scholz EP; Bloehs R; Kathöfer S; Thomas D; Bauer A; Katus HA; Karle CA; Kiesecker C
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):73-83. PubMed ID: 18458880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cardiac HERG currents by the DNA topoisomerase II inhibitor amsacrine: mode of action.
    Thomas D; Hammerling BC; Wu K; Wimmer AB; Ficker EK; Kirsch GE; Kochan MC; Wible BA; Scholz EP; Zitron E; Kathöfer S; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Br J Pharmacol; 2004 Jun; 142(3):485-94. PubMed ID: 15148258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X).
    Thomas D; Hammerling BC; Wimmer AB; Wu K; Ficker E; Kuryshev YA; Scherer D; Kiehn J; Katus HA; Schoels W; Karle CA
    Cardiovasc Res; 2004 Dec; 64(3):467-76. PubMed ID: 15537500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cardiac HERG potassium channels by the atypical antidepressant trazodone.
    Zitron E; Kiesecker C; Scholz E; Lück S; Bloehs R; Kathöfer S; Thomas D; Kiehn J; Kreye VA; Katus HA; Schoels W; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):146-56. PubMed ID: 15322737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protriptyline block of the human ether-à-go-go-related gene (HERG) K+ channel.
    Jo SH; Hong HK; Chong SH; Choe H
    Life Sci; 2008 Jan; 82(5-6):331-40. PubMed ID: 18191158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.
    Kiesecker C; Zitron E; Lück S; Bloehs R; Scholz EP; Kathöfer S; Thomas D; Kreye VA; Katus HA; Schoels W; Karle CA; Kiehn J
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):423-35. PubMed ID: 15599706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
    Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT
    Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole inhibits hERG K(+) channel by direct block and disruption of protein trafficking.
    Han S; Zhang Y; Chen Q; Duan Y; Zheng T; Hu X; Zhang Z; Zhang L
    Eur J Pharmacol; 2011 Jan; 650(1):138-44. PubMed ID: 20951697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modulation of HERG channels by organochlorine solvent trichlormethane as potential explanation for proarrhythmic effects of chloroform.
    Scholz EP; Alter M; Zitron E; Kiesecker C; Kathöfer S; Thomas D; Kreye VA; Kreuzer J; Becker R; Katus HA; Greten J; Karle CA
    Toxicol Lett; 2006 Aug; 165(2):156-66. PubMed ID: 16647228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: trazodone as a case example.
    Rodriguez-Menchaca AA; Ferrer T; Navarro-Polanco RA; Sanchez-Chapula JA; Moreno-Galindo EG
    J Pharmacol Toxicol Methods; 2014; 69(3):237-44. PubMed ID: 24412489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H(1) antihistamine drug promethazine directly blocks hERG K(+) channel.
    Jo SH; Hong HK; Chong SH; Lee HS; Choe H
    Pharmacol Res; 2009 Nov; 60(5):429-37. PubMed ID: 19497368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
    Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
    Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic antiparkinson drug orphenadrine inhibits HERG channels: block attenuation by mutations of the pore residues Y652 or F656.
    Scholz EP; Konrad FM; Weiss DL; Zitron E; Kiesecker C; Bloehs R; Kulzer M; Thomas D; Kathöfer S; Bauer A; Maurer MH; Seemann G; Katus HA; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):275-84. PubMed ID: 17965852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.
    Duan JJ; Ma JH; Zhang PH; Wang XP; Zou AR; Tu DN
    Acta Pharmacol Sin; 2007 Jul; 28(7):959-67. PubMed ID: 17588331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.